Health Catalyst, Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed on October 27, 2023, by Health Catalyst, Inc. (HCAT), a healthcare technology company. The report serves to disclose the issuance of a press release containing preliminary financial results for the quarter ended September 30, 2023.
Key Financial Metrics
The filing text itself does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release attached as Exhibit 99.1, which is incorporated by reference but not detailed in the body of this 8-K.
Material Changes
No material changes or comparative financial data are explicitly stated in the text of this filing. The document solely announces the availability of the preliminary results for the quarter ended September 30, 2023.
Guidance, Outlook, and Risks
The filing does not contain management commentary, forward-looking guidance, risk factors, or details on contingencies. It notes that the information furnished is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section.
Investor Verification Checklist
- Review Exhibit 99.1 (the press release) for specific revenue, earnings, and cash flow figures for the quarter ended September 30, 2023.
- Verify the company's updated financial guidance and outlook provided in the referenced press release.
- Confirm the status of the company's liquidity and debt obligations as detailed in the full preliminary results.
- Check for any unusual items or one-time charges disclosed in the attached exhibit.